36 results
PRE 14A
TPST
Tempest Therapeutics, Inc.
22 Apr 22
Preliminary proxy
4:01pm
in 2021
Financial Expert
Committee Chair
Committee Member
Chair of the Board
Dr. Xu’s service on the Audit Committee and Compensation Committee … that Ms. Pellizzari is an “audit committee financial expert” within the meaning of SEC regulations. Each member of the Audit Committee can read
8-K
EX-10.1
TPST
Tempest Therapeutics, Inc.
7 Jul 21
Departure of Directors or Certain Officers
5:18pm
, to a Covered Entity by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by a Covered Entity
424B3
gtnxm
11 May 21
Prospectus supplement
5:19pm
8-K
EX-2.1
wxp26y
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
425
EX-2.1
r29dm5rkr7u4vyo
29 Mar 21
Business combination disclosure
7:27am
8-K
EX-10.1
c8e28ee hyfayhhf
13 Dec 18
Millendo Therapeutics Announces Successful Merger Completion
4:08pm
8-K
EX-10.4
y8f 847m5v
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
EX-10.3
hdkqn6zbk5iymxzyk02i
6 Dec 18
Entry into a Material Definitive Agreement
6:18am